Edwards Lifesciences (EW) EV to FCF (2009 - 2026)

Edwards Lifesciences has reported EV to FCF for 18 years, with the latest figure at 82.07 in Q2 2026.

• On a quarterly basis, EV to FCF fell 52.9% year-over-year to 82.07 in Q2 2026; TTM through Jun 2026 was 33.49, a 53.1% decrease from a year earlier, with the FY2025 full-year figure at 33.92, down 75.21% from the prior year.
• EV to FCF was 82.07 for Q2 2026 at Edwards Lifesciences, up from 2015.86 in the prior quarter.
• The five-year high for EV to FCF was 916.57 in Q4 2023, with the low at 3909.42 in Q2 2023.
• Average EV to FCF over 5 years is 196.06, with a median of 150.17 recorded in 2025.
• The largest YoY upside for EV to FCF was 343.86% in 2023 against a maximum downside of 2068.29% in 2023.
• Over 5 years, EV to FCF stood at 206.5 in 2022, then soared by 343.86% to 916.57 in 2023, then slumped by 124.41% to 223.7 in 2024, then soared by 157.26% to 128.09 in 2025, then plunged by 35.92% to 82.07 in 2026.
• The last three EV to FCF figures came in at 82.07 (Q2 2026), 2015.86 (Q1 2026), and 128.09 (Q4 2025), per Business Quant data.